This report studies Human Insulin in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Sanofi (France) Eli Lilly and Company (U.S.) Biocon Ltd. (India) Julphar (U.A.E.) Ypsomed AG (Switzerland) Becton Dickinson and Company (U.S.) Wockhardt Ltd. (India) B. Braun Meselgen AG (Switzerland) Biodel Inc(U.S.) By types, the market can be split into Short Acting Human Insulin Intermediate Acting Human Insulin Premixed Human Insulin By Application, the market can be split into Insulin Dependent Diabetes Mellitus Non-Insulin Dependent Diabetes Mellitus By Regions, this report covers (we can add the regions/countries as you want) North America China Europe Southeast Asia Japan India
Table of Contents Global Human Insulin Market Professional Survey Report 2017 1 Industry Overview of Human Insulin 1.1 Definition and Specifications of Human Insulin 1.1.1 Definition of Human Insulin 1.1.2 Specifications of Human Insulin 1.2 Classification of Human Insulin 1.2.1 Short Acting Human Insulin 1.2.2 Intermediate Acting Human Insulin
